Which statement is true regarding adverse events in TB treatment?

The statement that all adverse events (AEs) should be reported to national authorities is accurate because it highlights the importance of comprehensive monitoring and data collection in tuberculosis (TB) treatment.

Reporting all AEs allows public health officials to gather essential information about the safety and effectiveness of TB medications across diverse populations. This data can be invaluable for identifying trends, assessing the overall impact of the treatment protocols, and making necessary adjustments to improve patient safety and outcomes.

Monitoring AEs goes beyond just serious adverse events (SAEs); even less severe AEs can provide critical insights into drug tolerance and patient management strategies. By compiling data on all AEs, health authorities can enhance their understanding of the side effects associated with TB treatments and refine guidelines to better mitigate these risks during TB control programs.